What the agency says to do
FDA’s record gives no instruction for consumers.
Status: Ongoing. What the FDA’s recall statuses mean (opens in a new tab)
Note from Recalls Watch, not agency text
- Talk to your pharmacist or doctor before you stop taking a medicine. FDA: Medication Guides and your medicines (opens in a new tab)
- In an emergency call 911. For a possible poisoning call Poison Help at 1-800-222-1222. Poison Help (HRSA) (opens in a new tab)
- For refunds, repairs or replacements, follow the agency notice. Recalls.gov (opens in a new tab)
Why it was recalled
CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit
FDA classification: Class II. What the FDA’s classes mean (opens in a new tab)
The recalled product
Codes in the record. Click one to copy it.
1 more codes are in the record below.
Dabigatran Etexilate, 75 mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-474-60
- Lot or code
- Lot #: 24142328, 24142329, 24142330, Exp. Date May 31, 2026.
- FDA recall number
- D-0129-2025
- Quantity
- 1971 bottles
Dabigatran Etexilate, 150mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-475-60
- Lot or code
- Lot #: 24142192, 24142193, 24142194, Exp. Date April 30, 2026; 24142463, Exp. Date May 31, 2026;
- FDA recall number
- D-0130-2025
- Quantity
- 10,444 bottles
Distribution (FDA): Nationwide within the United States
Source
- Issued by
- U.S. Food and Drug Administration
- Firm
- Ascend Laboratories, LLC
- Title
- Composed by Recalls Watch from fields of the record; FDA records have no title.